What is the role for lithium in postpartum psychosis? What do we know about mood stabilizers and breastfeeding? Is it possible for women who are using lithium to breastfeed in a safe manner? If your patient is already on a mood stabilizer, should she switch medications specifically for breastfeeding?
Specific tests that you need to order before prescribing lithium (baseline testing). How to start lithium. The best way to distribute dosing to prevent kidney damage. The most relevant drug interactions that may affect lithium levels.
Antipsychotic-induced weight gain is a huge problem. Today's episode will remind you of some important concepts from the general medicine perspective. This episode will help you be more systematic about the diagnosis of metabolic syndrome in your clinical practice. It will also give you a framework for monitoring metabolic side effects when you prescribe second-generation antipsychotics.
Why is akathisia important? For differential diagnosis, what are the most common conditions that can mimic akathisia? What is pseudoakathisia? What can you do to treat akathisia before adding any new medication? If you need to add a medication, which one should you choose?
How common is postpartum psychosis? What underlying etiology should we always suspect? How do we differentiate postpartum psychosis from obsessive-compulsive disorder in the postpartum? Is postpartum psychosis an emergency, or can it be handled with outpatient treatment?
This episode explores a clinical trial on the use of hypnotics in insomnia associated with suicidal depression.
In this podcast, we discuss behavioral and psychopharmacologic management strategies for COVID-19–related delirium.
We discuss a study on the use of the mu-opioid receptor antagonist, samidorphan for olanzapine-induced weight gain, compared to placebo and naltrexone.
We discuss the prevalence and treatment of depression, psychosis in patients with Parkinson’s Disease.
Management of Psychiatric Disturbances in Parkinson’s Disease and Other Hypokinetic Movement Disorders
We review a study on the management of psychiatric disturbances in Parkinson’s Disease and atypical parkinsonisms.